| Medical Genetics | Lifetime | 7 | DE 1 | 99.92 |
| Cancer Research | Lifetime | 819 | DE 43 | 94.04 |
| Biological Psychiatry | Lifetime | 243 | DE 13 | 80.90 |
| Medical Genetics | 2021-2025 | 18 | DE 4 | 99.56 |
| Oncology | 2021-2025 | 625 | DE 33 | 90.65 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 781 | DE 37 | 89.76 |
| Clinical Neurology | 2021-2025 | 419 | DE 21 | 85.60 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 767 | DE 50 | 81.99 |
| Immunology | 2021-2025 | 694 | DE 49 | 78.21 |
| Glioma Diagnosis and Treatment | Lifetime | 5 | DE 2 | 99.96 |
| Brain Metastases and Treatment | Lifetime | 5 | DE 1 | 99.92 |
| Radiomics and Machine Learning in Medical Imaging | Lifetime | 76 | DE 8 | 99.57 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 105 | DE 10 | 99.59 |
| Histone Deacetylase Inhibitors Research | Lifetime | 43 | DE 3 | 99.44 |
| Epigenetics and DNA Methylation | Lifetime | 242 | DE 16 | 99.26 |
| Meningioma and schwannoma management | Lifetime | 80 | DE 11 | 99.40 |
| Immune cells in cancer | Lifetime | 275 | DE 30 | 98.43 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 624 | DE 33 | 98.63 |
| Neuroblastoma Research and Treatments | Lifetime | 261 | DE 26 | 98.42 |
| Cancer Research and Treatments | Lifetime | 477 | DE 20 | 97.49 |
| MRI in cancer diagnosis | Lifetime | 385 | DE 39 | 97.92 |
| Chromatin Remodeling and Cancer | Lifetime | 194 | DE 25 | 94.83 |
| TGF-β signaling in diseases | Lifetime | 346 | DE 19 | 95.17 |
| Cancer Mechanisms and Therapy | Lifetime | 600 | DE 38 | 94.36 |
| Cell death mechanisms and regulation | Lifetime | 969 | DE 88 | 94.12 |
| Vascular Malformations Diagnosis and Treatment | Lifetime | 960 | DE 65 | 94.59 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 611 | DE 52 | 93.38 |
| Neurofibromatosis and Schwannoma Cases | Lifetime | 946 | DE 84 | 92.04 |
| Cancer-related cognitive impairment studies | Lifetime | 855 | DE 35 | 85.37 |
| Mechanisms of cancer metastasis | Lifetime | 957 | DE 41 | 58.39 |
| Glioma Diagnosis and Treatment | 2021-2025 | 8 | DE 2 | 99.84 |
| Brain Metastases and Treatment | 2021-2025 | 9 | DE 1 | 99.44 |
| Immunotherapy and Immune Responses | 2021-2025 | 348 | DE 21 | 95.50 |
| Meningioma and schwannoma management | 2021-2025 | 370 | DE 45 | 91.75 |
| Cancer Research and Treatments | 2021-2025 | 520 | DE 7 | 84.27 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 476 | DE 37 | 83.57 |
| CNS Lymphoma Diagnosis and Treatment | 2021-2025 | 460 | DE 41 | 79.96 |
| Chromatin Remodeling and Cancer | 2021-2025 | 287 | DE 46 | 75.31 |
| Cancer-related cognitive impairment studies | 2021-2025 | 501 | DE 14 | 75.66 |
